Pliant Therapeutics (PLRX) News
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.02+0.02 (+2.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PLRX news summary
We found 1 recent headline mentioning Pliant Therapeutics (PLRX): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, PLRX is up 2.00% at $1.02. The most recent story, "Pliant Therapeutics Names David Raben As CMO To Lead PLN-101095 Development", was published by Nasdaq on Oct 1, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology